The Intricate Relationship Between Pulmonary Fibrosis and Thrombotic Pathology: A Narrative Review
2024

The Relationship Between Pulmonary Fibrosis and Thrombotic Events

publication Evidence: moderate

Author Information

Author(s): Cenerini Giovanni, Chimera Davide, Pagnini Marta, Bazzan Erica, Conti Maria, Turato Graziella, Celi Alessandro, Neri Tommaso

Primary Institution: Università degli Studi di Pisa

Hypothesis

The review explores the bidirectional relationship between pulmonary fibrosis and thrombosis.

Conclusion

The study highlights the complex interplay between pulmonary fibrosis and thrombotic events, suggesting that both conditions exacerbate each other.

Supporting Evidence

  • Idiopathic pulmonary fibrosis (IPF) is linked to a higher risk of thrombotic events.
  • Coagulation factors can promote fibrosis, while fibrosis can activate thrombotic pathways.
  • Extracellular vesicles play a significant role in linking fibrosis and coagulation.
  • Anticoagulants may benefit IPF patients, but evidence from prospective trials is limited.
  • Targeting specific coagulation pathways may offer new therapeutic strategies for IPF.

Takeaway

Pulmonary fibrosis can make people more likely to have blood clots, and blood clots can make pulmonary fibrosis worse.

Methodology

This is a narrative review discussing epidemiological evidence, mechanisms, and therapeutic implications.

Limitations

The review is based on existing literature and may not include all recent studies.

Digital Object Identifier (DOI)

10.3390/cells13242099

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication